Novo Nordisk A/S: Transaction in Own Shares

BAGSVAERD, DENMARK--(Marketwire - March 16, 2009) - Novo Nordisk A/S - Share repurchase programme

On 29 January 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.

Since the announcement as of 9 March 2009, the following transactions have been made under the programme:

                Number of      Average   Transaction value,
                 shares       purchase          DKK
                              price
Accumulated,
last            2,040,000                   608,016,770
announcement
9 March 2009       80,000      258.96        20,716,800
10 March 2009      75,000      257.11        19,283,400
11 March 2009      75,000      264.76        19,857,000
12 March 2009      75,000      264.60        19,845,000
13 March 2009      75,000      267.74        20,080,500
Accumulated
under the       2,420,000                   707,799,470
programme

With the transactions stated above, Novo Nordisk owns a total of 27,272,552 treasury shares, corresponding to 4.3% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 27,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Further information:

Media:                 Investors:

Outside North America: Outside North America:
Mette Kruse Danielsen  Mads Veggerby Lausten
Tel: (+45) 4442 3883   Tel: (+45) 4443 7919
mkd@novonordisk.com    mlau@novonordisk.com

                       Kasper Roseeuw Poulsen
                       Tel: 4442 4471
                       krop@novonordisk.com

In North America:      In North America:
Sean Clements          Hans Rommer
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com   hrmm@novonordisk.com

Company Announcement no 14 / 2009

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.